Growth factors have been implicated in many important functions in the retina, including development and differentiation, cell survival, and wound repair. They have also been implicated in the pathogenesis of several disease processes including exaggerated wound repair leading to scarring and retinal detachment, ocular neovascularization, and retinal degenerations. In order to modulate the normal and pathologic roles of growth factors, it is important to have a detailed understanding of how alterations in their expression in the retina affect retinal structure and function. In past grant periods, we have demonstrated that the expression of platelet-derived growth factor (PDGF)-A and PDGF-B, and their receptors are increased in vitro and in vivo in models of retinal and retinal pigmented epithelial (RPE) cell wound repair and proliferative retinopathies, while fibroblast growth factor (FGF) signaling is necessary for photoreceptor cell survival. In this grant period, we plan to use tissue- specific promoters in transgenic mice to study the effects of altered expression of each of these factors in the retina. Using photoreceptor- specific promoters (rhodopsin or inter photoreceptor retinol binding protein) or the neuron-specific enolase promoter, which drives expression in the inner retina, we will control the location of expression in the retina. In addition, we will use the tetracycline-induced promoter system to control the timing and duration of expression. We will determine the effect of altered expression of these factors in the retina at various stages of development and in several models of proliferative retinopathies or retinal degenerations. This will provide important new information that is needed for the development of new treatments for these disease processes.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY005951-18
Application #
6476309
Study Section
Special Emphasis Panel (ZRG1-VISC (01))
Program Officer
Dudley, Peter A
Project Start
1985-09-30
Project End
2004-11-30
Budget Start
2001-12-01
Budget End
2002-11-30
Support Year
18
Fiscal Year
2002
Total Cost
$540,299
Indirect Cost
Name
Johns Hopkins University
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Shen, Jikui; Choy, David F; Yoshida, Tsunehiko et al. (2014) Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF. J Cell Physiol 229:974-83
Ohnaka, Masayuki; Miki, Katsuaki; Gong, Yuan-Yuan et al. (2012) Long-term expression of glial cell line-derived neurotrophic factor slows, but does not stop retinal degeneration in a model of retinitis pigmentosa. J Neurochem 122:1047-53
Usui, Shinichi; Oveson, Brian C; Iwase, Takeshi et al. (2011) Overexpression of SOD in retina: need for increase in H2O2-detoxifying enzyme in same cellular compartment. Free Radic Biol Med 51:1347-54
Oveson, Brian C; Iwase, Takeshi; Hackett, Sean F et al. (2011) Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degeneration. J Neurochem 116:144-53
Dong, Aling; Xie, Bing; Shen, Jikui et al. (2009) Oxidative stress promotes ocular neovascularization. J Cell Physiol 219:544-52
Lu, Lili; Oveson, Brain C; Jo, Young-Joon et al. (2009) Increased expression of glutathione peroxidase 4 strongly protects retina from oxidative damage. Antioxid Redox Signal 11:715-24
Usui, Shinichi; Oveson, Brian C; Lee, Sun Young et al. (2009) NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa. J Neurochem 110:1028-37
Usui, Shinichi; Komeima, Keiichi; Lee, Sun Young et al. (2009) Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa. Mol Ther 17:778-86
Komeima, Keiichi; Usui, Shinichi; Shen, Jikui et al. (2008) Blockade of neuronal nitric oxide synthase reduces cone cell death in a model of retinitis pigmentosa. Free Radic Biol Med 45:905-12
Chowers, Itay; Wong, Robert; Dentchev, Tzvete et al. (2006) The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 47:2135-40